It's time for the Lightning Round. Cramer makes the call on viewer favorites.» Read More
NEW YORK— Medical device maker Stryker said Monday it will buy bone and joint replacement maker Small Bone Innovations for up to $375 million in cash. Small Bone Innovations is based in Morrisville, Pennsylvania, with facilities in France and Germany. Shares of Stryker Corp. rose 28 cents to $84.25 in afternoon trading.
NEW YORK, June 19- It's the secret fear of every American parent: failure to launch. The idea used to give Andy Byron the cold sweats. Their 22- year-old son scored a paid summer internship with medical device manufacturer Stryker Corp, with an eye toward a career in medical sales.
June 16- Medtronic Inc's $43 billion deal for Dublin- based Covidien Plc should accelerate already intense efforts by medical device rivals to seek merger partners, industry analysts and bankers said on Monday.
One of the world's largest makers of medical devices, Medtronic, is considering a takeover of London-based Smith & Nephew, Bloomberg said.
Jim Cramer thinks there’s something Johnson & Johnson could do, right now, to create significant shareholder value.
More and more foreign buyers are finding the U.K.'s takeover laws difficult to navigate.
Some of Thursday's midday movers:
Some of Wednesday's midday movers:
April 15- ConMed Corp, a surgical device maker that has been fighting off activist investors, is exploring a sale and has contacted large medical device companies to gauge their buyout interest, people familiar with the matter said on Tuesday.
WASHINGTON, March 31- Bariatric weight loss surgery on obese patients with type 2 diabetes helped many to get their blood sugar to healthy levels and to no longer require any diabetes medicines, including insulin, three years after the procedure, according to data presented at a major medical meeting on Monday.
March 7- U.S. medical devices maker Biomet Inc filed with U.S. regulators on Friday to raise up to $100 million in an initial public offering of its common shares as its private equity owners look to cash out. The company, which was taken private for $11.4 billion in 2007, said BofA Merrill Lynch, Goldman Sachs and J.P. Morgan were the lead underwriters to the offering.
Excluding items such as product recall and acquisition charges, Stryker earned $1.23 per share, just ahead of the $1.22 per-share forecast, on average, by Wall Street analysts, according to Thomson Reuters I/B/E/S. The company reported fourth-quarter net earnings of $386 million, or $1.01 per share, compared with $270 million, or 71 cents a share a year earlier.
Some of Tuesday's midday movers:
Worried about Washington's next fiscal folly? These stocks should weather the next storm, according to two top money managers.
Stryker CEO Kevin Lobo says his company is in "great shape," and discusses the gradual increase in people electing to have surgery. He also addresses the hit from recall costs.
Check out which companies are making headlines after the bell Thursday:
With Washington's debt battle over, markets will quickly shift focus to earnings and how much the government shutdown actually impacted the economy.
A detailed look at how a tax on medical devices divided so many over the White House's Affordable Care Act.
OptionMonster's Jon Najarian points out what looks to be unusual activity in Stryker and Mako options ahead of their merger announcement.
Stocks ended lower Wednesday, with the Dow and S&P closing in the red for the fifth-straight day, as jitters over budget talks in Washington continued to weigh on markets.